CSIMarket
 

Sarepta Therapeutics Inc   (SRPT)
Other Ticker:  
 

Sarepta Therapeutics Inc 's Working Capital Per Sales

SRPT's Working Capital and Revenue growth



SRPT Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change -4.24 % 0.3 % -6.77 % -9.51 % 11.11 %
Y / Y Revenue Change 44.1 % 11.89 % 20.24 % 28.28 % 21.57 %
Working Capital Per Revenue 1.83 2.04 2.09 2.23 2.43
Total Ranking # 1888 # 2861 # 2423 # 56 # 2139
Seq. Working Capital Change 0.18 % 0.01 % -0.43 % -4.01 % 4.93 %
Seq. Revenue Change 27.02 % 3.05 % -1.91 % 12.23 % -1.38 %





Comment on SRPT's Working Capital Per Revenue in the third quarter 2023
Sarepta Therapeutics Inc 's Working Capital Per Revenue in the Q3 2023 sequentially fell to 1.83 below the company average.

Within Healthcare sector 20 other companies have achieved lower Working Capital Per Revenue during the Q3 2023. While Sarepta Therapeutics Inc Working Capital Per Revenue overall ranking has impoved so far in the Q3 2023 to 1888, from total ranking in the second quarter 2023 at 2861.
Working Capital Per Revenue Ranking
Within: No.
Industry # 6
Sector # 21
S&P 500 # 1888


Working Capital Per Revenue Statistics
High Average Low
19.6
4.26
1.78
(Sep. 30, 2014)   (Sep 30 2023)



Financial Statements
Sarepta Therapeutics Inc 's Working Capital $ 2,023 Millions Visit SRPT's Balance sheet
Sarepta Therapeutics Inc 's Revenues $ 332 Millions Visit SRPT's Income Statement
Where are SRPT's Sales coming from? Visit SRPT's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Werewolf Therapeutics Inc   4.94 
Arvinas Inc   4.90 
Xenetic Biosciences Inc   4.88 
Uniqure N v   4.67 
Nektar Therapeutics  4.66 
Aligos Therapeutics Inc   4.59 
Prothena Corporation Public Limited Company  4.55 
Liquidia Corporation  4.48 
Eiger Biopharmaceuticals Inc   4.38 
Universal Biosensors Inc   4.37 
Repare Therapeutics Inc   4.34 
Perspective Therapeutics Inc   3.99 
Rhythm Pharmaceuticals inc   3.98 
Theravance Biopharma inc   3.96 
Pacific Biosciences Of California Inc   3.95 
Siga Technologies Inc  3.94 
Enanta Pharmaceuticals Inc  3.91 
Poseida Therapeutics Inc   3.87 
Xencor Inc  3.86 
Butterfly Network inc   3.83 
Pulmatrix Inc   3.81 
Lineage Cell Therapeutics Inc   3.80 
Igc Pharma Inc   3.63 
Blueprint Medicines Corporation  3.53 
Ginkgo Bioworks Holdings Inc   3.53 
Ionis Pharmaceuticals Inc  3.53 
Zai Lab Limited  3.46 
Fate Therapeutics Inc   3.41 
Neurometrix Inc   3.31 
Nurix Therapeutics Inc   3.26 
Date modified: 2023-11-02T13:32:47+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com